Who raised $280 million at $1.4 billion valuation and is Zionist an offensive term?
CTech Daily Roundup: Covid-19 Big Bang sending trillion-dollar shockwaves through media market
Covid-19 Big Bang sending trillion-dollar shockwaves through media market. Gilad de Vries, SVP at content recommendations platform Outbrain, believes the public is losing faith in what it is reading on social media, pushing advertising dollars back towards traditional media websites. Read more
Israel’s Otonomo to raise $280 million at $1.4 billion valuation via SPAC. “Auto companies cast aside their technological developments and they will have to search for solutions after the crisis is over,” says CEO. Read more
EarlySense. Photo: EarlySense
“We are concerned about the over-exuberance we’re seeing in the markets.” ISA’s Sarah Kendler is glad to see tech companies call Israel home, but expresses worry over riskier investment practices arriving to Tel Aviv. Read more
Earlysense sells its intellectual property rights for $30 million. Company’s technology can be used to treat patients and hospitalize them at home. As part of deal, it setback Hillrom from primary to secondary shareholder. Read more
Facebook's new dilemma: Is Zionist an offensive term? The social media giant admitted that the term “Zionist” is under review as it attempts to determine how it should moderate against anti-Semitism. Read more
HR Post Covid | For HR leaders, one of the most important things “is to see the people,” says StackPulse. It’s one thing for companies to adapt to social distancing and remote working, but StackPulse was founded in it. Read more
Opinion | Top 9 tech areas that are changing sports in 2021. The sports industry is one of the last industries to be truly disrupted by technology and the recent crisis is the catalyzer that will introduce radical innovation in the sports world. Read more
Analysis | Even without earnings, BladeRanger is the stuff of dreams for investors. The Israeli company develops robots to clean solar panels and is only expected to begin yielding revenue in 2022, but its stock leapt by 156% since its December IPO. Read more
Opinion | From survival stagnation to proactive thinking in the post-Covid-19 era. The distance between survival stagnation and proactive thinking that sees the crisis as an opportunity is shorter than we think, argues Amdocs’ Gil Rosen. Read more
